Mark Costanzo is President, Renal Therapies Group of Fresenius Medical Care North America effective January 1, 2010. He currently directs the overall Renal Products and Pharmaceutical operations including Sales, Marketing, Medical & Regulatory Affairs as well as RRI, Mexico and Canada Operations. Mark joined Fresenius Medical Care in 1990 and has held several positions including Vice President, Peritoneal Dialysis Products, Vice President, Sales & Marketing, and currently, President, Renal Therapies Group. He began his career in the renal industry with Baxter International Inc. and has 30 years of experience in this business. Mark has been instrumental in the development and market launch of many new products at Fresenius Medical Care.
KHI Member support provided by: Fresenius Medical Care North America